Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
14 studies found for:    DIAN
Show Display Options
Rank Status Study
1 Recruiting Dominantly Inherited Alzheimer Network (DIAN)
Condition: Alzheimer's Disease
2 Active, not recruiting Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
Conditions: Alzheimers Disease;   Dementia;   Alzheimers Disease, Familial
Interventions: Drug: Gantenerumab;   Drug: Solanezumab;   Drug: Matching Placebo (Gantenerumab);   Drug: Matching Placebo (Solanezumab)
3 Recruiting F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)
Condition: Alzheimer Disease
Intervention: Drug: F 18 T807
4 Recruiting A Prospective, Observational, Real-world Study Based on the Register System of Oral and Maxillofacial Malignant Tumors
Conditions: Head and Neck Neoplasms;   Quality of Life;   Postoperative Complications
Interventions: Procedure: resection;   Radiation: adjuvant radiotherapy;   Drug: neoadjuvant chemotherapy or adjuvant chemotherapy
5 Recruiting High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study
Condition: Tuberculosis, Meningeal
Interventions: Drug: Placebo;   Drug: Rifampicin;   Drug: Other TB drugs;   Drug: Adjuvant dexamethasone
6 Completed Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: S-1;   Drug: S-1 plus CDDP;   Drug: 5-FU plus CDDP
7 Completed A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Deferiprone oral solution 100mg/mL;   Drug: Deferiprone oral solution 100 mg/mL
8 Completed A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: placebo;   Drug: deferiprone
9 Completed
Has Results
Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients
Condition: Iron Overload
Intervention: Drug: Deferiprone
10 Active, not recruiting Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
Conditions: Lymphedema;   Musculoskeletal Complications;   Radiation Fibrosis;   Radiation Toxicity;   Sarcoma
Interventions: Drug: chemotherapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
11 Not yet recruiting Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI
Condition: Rectal Neoplasms
Intervention: Device: three MR examination
12 Recruiting Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Conditions: Adult Fibrosarcoma;   Alveolar Soft Part Sarcoma;   Angiomatoid Fibrous Histiocytoma;   Atypical Fibroxanthoma;   Clear Cell Sarcoma of Soft Tissue;   Epithelioid Malignant Peripheral Nerve Sheath Tumor;   Epithelioid Sarcoma;   Extraskeletal Myxoid Chondrosarcoma;   Extraskeletal Osteosarcoma;   Fibrohistiocytic Neoplasm;   Glomus Tumor of the Skin;   Inflammatory Myofibroblastic Tumor;   Intimal Sarcoma;   Leiomyosarcoma;   Liposarcoma;   Low Grade Fibromyxoid Sarcoma;   Low Grade Myofibroblastic Sarcoma;   Malignant Cutaneous Granular Cell Tumor;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Triton Tumor;   Mesenchymal Chondrosarcoma;   Myxofibrosarcoma;   Myxoid Chondrosarcoma;   Myxoinflammatory Fibroblastic Sarcoma;   Nerve Sheath Neoplasm;   PEComa;   Pericytic Neoplasm;   Plexiform Fibrohistiocytic Tumor;   Sclerosing Epithelioid Fibrosarcoma;   Stage IB Soft Tissue Sarcoma;   Stage IIB Soft Tissue Sarcoma;   Stage III Soft Tissue Sarcoma;   Stage IV Soft Tissue Sarcoma;   Synovial Sarcoma;   Undifferentiated (Embryonal) Sarcoma;   Undifferentiated High Grade Pleomorphic Sarcoma of Bone
Interventions: Drug: Doxorubicin Hydrochloride;   Drug: Ifosfamide;   Other: Laboratory Biomarker Analysis;   Drug: Pazopanib Hydrochloride;   Other: Pharmacological Study;   Radiation: Radiation Therapy;   Procedure: Therapeutic Conventional Surgery
13 Unknown  Efficacy Study of Multiple Micro Nutrients Supplementation
Condition: Anemia, Iron-deficiency
Interventions: Dietary Supplement: Multi-micronutrients;   Dietary Supplement: Maltodextrin and Lactose
14 Recruiting Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC
Condition: Non Small Cell Lung Cancer
Intervention: Other: Microwave ablation

Indicates status has not been verified in more than two years